[Anaphylactoid reaction caused by intravenous gadopentetate dimeglumine in magnetic resonance].
Campos
A
A
Aznar
L
L
Alamar
R
R
Castelló
J V
JV
D000707:Anaphylaxis / Q000139:chemically induced*; D003287:Contrast Media / Q000008:administration & dosage / Q000009:adverse effects*; D004338:Drug Combinations; D005260:Female; D005682:Gadolinium / Q000008:administration & dosage / Q000009:adverse effects*; D019786:Gadolinium DTPA; D006801:Humans; D007275:Injections, Intravenous; D008279:Magnetic Resonance Imaging / Q000009:adverse effects*; D008536:Meglumine / Q000008:administration & dosage / Q000009:adverse effects*; D008875:Middle Aged; D009942:Organometallic Compounds / Q000008:administration & dosage / Q000009:adverse effects*; D004369:Pentetic Acid / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*
D003287:Contrast Media; D004338:Drug Combinations; D009942:Organometallic Compounds; D008536:Meglumine; D004369:Pentetic Acid; D005682:Gadolinium; D019786:Gadolinium DTPA
Reacción anafilactoide por gadopentetato de dimeglumina intravenoso en una resonancia magnética.